drugset / Trial / NCT03067610

Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer

NCT03067610 ↗

Phase 2 Completed 72 enrolled University of Texas Southwestern Medical Center
NaSingle-groupOpen-labelTreatment

Summary

Intensity modulated radiation therapy (IMRT) with or without chemotherapy (if given, either cisplatin, cetuximab, or carboplatin-paclitaxel)

Timeline

Start
2017-01-20
Primary completion
2020-12-21
Completion
2021-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — —
Subject Cetuximab Monoclonal antibody — —
Subject Cisplatin Other / unclassified — —
Subject Paclitaxel Small molecule — —